Literature DB >> 12792494

Successful segmental auxiliary liver transplantation from a non-heart-beating donor: implications for split-liver transplantation.

Paolo Muiesan1, Raffaele Girlanda, Alistair Baker, Mohamed Rela, Nigel Heaton.   

Abstract

BACKGROUND: Liver transplantation (LT) using grafts from non-heart-beating donors (NHBDs) has been shown to be a successful practice. Recently reported primary nonfunction rates are similar to those of LT using grafts from brain-dead donors.
METHOD: We report the use of an NHBD liver, which was cut into a right-lobe graft and implanted as an auxiliary partial orthotopic liver transplant for acute liver failure in a 11-year-old child. The warm ischemia time was 21 minutes, and the cold ischemia was 8 hours.
RESULTS: Initial graft function was excellent, and the child is well, with normal liver function 2 months posttransplant.
CONCLUSION: Reduction and splitting of livers from NHBDs for transplantation is a realistic option, provided there is careful selection of the graft.

Entities:  

Mesh:

Year:  2003        PMID: 12792494     DOI: 10.1097/01.TP.0000069024.86527.0B

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Current status and recent advances of liver transplantation from donation after cardiac death.

Authors:  M Thamara Pr Perera; Simon R Bramhall
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts.

Authors:  Paolo Muiesan; Raffaele Girlanda; Wayel Jassem; Hector Vilca Melendez; John O'Grady; Matthew Bowles; Mohamed Rela; Nigel Heaton
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.